The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Lisinopril Grindeks 5 mg tablets

AS GrindeksPA22992/018/001

Main Information

Trade NameLisinopril Grindeks 5 mg tablets
Active SubstancesLisinopril Dihydrate
Dosage FormTablet
Licence HolderAS Grindeks
Licence NumberPA22992/018/001

Group Information

ATC CodeC09AA03 lisinopril


License statusAuthorised
Licence Issued19/05/2023
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back